我国生物样本库建设从“数量扩张”迈入“质量提升” 共享机制建立成行业焦点

Core Insights - The construction of biobanks in China has transitioned from "quantity expansion" to "quality enhancement," with a focus on establishing sharing mechanisms as a key discussion point in the industry [1][2] Group 1: Biobank Development - Biobanks are considered the "life banks" for storing human genetic resources, disease tissues, bodily fluids, and biomolecules, playing a crucial role in medical research, new drug development, and personalized treatment [1] - China has gradually built a high-standard biobank network covering all 31 provinces and cities, with ongoing developments towards standardization, automation, intelligence, and data utilization [1] Group 2: Challenges and Opportunities - Despite advancements in standard certification and quality control, challenges remain in sample sharing, data integration efficiency, collaboration between basic clinical and translational research, and the effectiveness of outcome translation [1] - The construction of biobanks in China is primarily hospital-led and discipline-focused, leading to issues such as redundant construction and information silos, indicating a need for improved sharing mechanisms and digital applications [2] Group 3: Regional Initiatives - The Minhang District in Shanghai is actively building a biobank safety system and promoting cross-industry interactions among universities, research institutions, and medical organizations [2] - The district has gathered numerous biopharmaceutical companies' R&D headquarters, forming a unique national-level characteristic industrial cluster for the gene industry [2]